Skip to main content
. 2022 Jan 19;14(3):492. doi: 10.3390/cancers14030492
CAK CDK-activating kinase
CDK7 Cyclin-dependent kinase 7
CI Confidence interval
DAB 3,3’-diaminobenzidine
DFS Disease-free survival
DM Distant metastasis
DSIF DRB-sensitivity-inducing factor
FFPE Formalin-fixed paraffin-embedded
HNSCC Head and neck squamous-cell cancer
HPV Human papilloma virus
HR Hazard ratio
IHC Immunhistochemistry
LN Lymph node metastasis
MAPK-ERK MAP-kinase
NELF Negative elongation factor
NR Nuclear receptor
NSCLC Non-small-cell lung cancer
OS Overall survival
PCC Pearson correlation coefficient
PD-L1 Programmed death ligand 1
pMED1 Phospho-mediator of RNA polymerase II transcription subunit 1
PT Primary tumor
RD Recurrence
RNA Pol II RNA polymerase II
ROI Region of interest
SE Super-enhancer
TMA Tissue microarray
TPS Tumor proportion score
UICC Union internationale contre le cancer